首页> 外文期刊>Acta Diabetologica >The glycemic and peak incremental indices of honey, sucrose and glucose in patients with type 1 diabetes mellitus: effects on C-peptide level—a pilot study
【24h】

The glycemic and peak incremental indices of honey, sucrose and glucose in patients with type 1 diabetes mellitus: effects on C-peptide level—a pilot study

机译:1型糖尿病患者蜂蜜,蔗糖和葡萄糖的血糖和峰值增量指数:对C肽水平的影响-一项初步研究

获取原文
获取原文并翻译 | 示例
       

摘要

Our study was a case–control cross-sectional study that was conducted on 20 children and adolescents suffering from type 1 diabetes mellitus and ten healthy non-diabetic children and adolescents serving as controls. The mean age of patients was 10.95 years. Oral sugar tolerance tests using glucose, sucrose and honey and measurement of fasting and postprandial serum C-peptide levels were done for all subjects in three separate sittings. The glycemic index (GI) and the peak incremental index (PII) were then calculated for each subject. Honey, compared to sucrose, had lower GI and PII in both patients (P < 0.001) and control (P < 0.05) groups. In the patients group, the increase in the level of C-peptide after using honey was not significant when compared with using either glucose or sucrose. However, in the control group, honey produced a significant higher C-peptide level, when compared with either glucose or sucrose. In conclusion, honey, because of its lower GI and PII when compared with sucrose, may be used as a sugar substitute in patients with type 1 diabetes mellitus.
机译:我们的研究是一项病例对照横断面研究,以20名患有1型糖尿病的儿童和青少年以及以10名健康的非糖尿病儿童和青少年作为对照进行。患者的平均年龄为10.95岁。使用葡萄糖,蔗糖和蜂蜜进行口服糖耐量测试,并在三个不同的座位上对所有受试者进行空腹和餐后血清C肽水平的测量。然后为每个受试者计算血糖指数(GI)和峰值增量指数(PII)。与蔗糖相比,蜂蜜在患者(P <0.001)和对照组(P <0.05)组中的GI和PII均较低。在患者组中,与使用葡萄糖或蔗糖相比,使用蜂蜜后C肽水平的增加并不显着。但是,在对照组中,与葡萄糖或蔗糖相比,蜂蜜产生的C肽水平高得多。总之,由于与蔗糖相比,它的GI和PII较低,因此可以将其用作1型糖尿病患者的糖替代品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号